Kidney Transplant: More than Immunological Problems.

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Kidney transplantation (KT) improves outcomes for chronic kidney disease (CKD) patients.
• KT recipients experience non-immunological complications, increasing cardiovascular (CV) and metabolic risks.
• Cardiovascular-Kidney-Metabolic (CKM) syndrome is a newly recognized entity impacting KT recipients.

Purpose of the Study:

• To review the intersection of cardio-metabolic syndrome and KT.
• To highlight the prevalence and impact of CKM syndrome in KT recipients.
• To discuss management strategies for CKM syndrome post-KT.

Main Methods:

• Literature review focusing on CKM syndrome in kidney transplant recipients.
• Analysis of the role of immunosuppressive therapies in CKM syndrome development.
• Examination of current and emerging management strategies.

Main Results:

• KT recipients are predisposed to CKM syndrome due to immunosuppression and CKD risks.
• Common complications include post-transplant hypertension, obesity, dyslipidemia, PTDM, and anemia.
• Immunosuppressants like corticosteroids, calcineurin inhibitors, and mTOR inhibitors exacerbate metabolic dysfunction.

Conclusions:

• CKM syndrome presents significant challenges for KT recipients.
• Tailored immunosuppressive strategies and multifaceted management are essential.
• Early intervention and risk stratification are key to optimizing outcomes and graft survival.